首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
NivolumabMyasthenia gravis: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2020年
/ 1788卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-020-74300-7
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:177 / 177
相关论文
共 50 条
[21]
NivolumabMyasthenia gravis and hypopituitarism: 2 case report
[J].
Reactions Weekly,
2019,
1775
(1)
: 349
-
349
[22]
Ipilimumab/nivolumabMyasthenia gravis like syndrome: case report
[J].
Reactions Weekly,
2019,
1765
(1)
: 201
-
201
[23]
Ipilimumab/nivolumabMyasthenia gravis, hepatitis and thyroiditis: case report
[J].
Reactions Weekly,
2020,
1810
(1)
: 122
-
122
[24]
NivolumabMyasthenia gravis and Guillain Barre syndrome: case report
[J].
Reactions Weekly,
2018,
1693
(1)
: 370
-
370
[25]
NivolumabMyasthenia gravis leading to necrotising myopathy and myocarditis: case report
[J].
Reactions Weekly,
2019,
1745
(1)
: 202
-
202
[26]
NivolumabMyasthenia gravis resulting in neuromuscular respiratory failure: case report
[J].
Reactions Weekly,
2018,
1683
(1)
: 513
-
513
[27]
Ipilimumab/nivolumabMyasthenia gravis, myositis, and sensorimotor polyneuropathy: case report
[J].
Reactions Weekly,
2018,
1686
(1)
: 214
-
214
[28]
NivolumabMyasthenia gravis, sinus bradycardia and complete atrioventricular block: Case report: case report
[J].
Reactions Weekly,
2018,
1712
(1)
: 399
-
399
[29]
NivolumabMyasthenia gravis: 12 case reports
[J].
Reactions Weekly,
2017,
1673
(1)
: 280
-
280
[30]
Ipilimumab/nivolumabMyasthenia gravis (first report for nivolumab) progressing to respiratory failure : case report
[J].
Reactions Weekly,
2015,
1564
(1)
: 128
-
128
←
1
2
3
4
5
→